Press release
Antidepressant Drugs Market Is Expected To Exhibit 2.1% CAGR By 2023 | Eli Lilly and Co., GlaxoSmithKline Plc
Antidepressant Drugs Market
The global antidepressant drugs market accounted for $14.11 billion in 2017 and is expected to reach $15.98 billion by 2023, registering a CAGR of 2.1% during the forecast period.
Download Detailed COVID-19 Impact Sample Report at @ https://www.alliedmarketresearch.com/request-for-customization/2593?reqfor=covid
COVID-19 scenario-
• Research and development activities have been conducted across the world in various universities and institutes. Researchers have suggested that anti-depressant drugs have an ability to lower down replication of viruses in Covid-19 infected patients.
• Due to disrupted supply chain and interruption in productions, the antidepressant drug manufacturers have been unable to meet the demand during the first few months of pandemic.
Increased global disease burden of depression, rise in geriatric population, and emergence of innovative techniques for the development of drugs with fewer side-effects drive the growth of the market. However, poor efficacy and safety profiles of drugs, inclination toward non-pharmacological therapies, and increase in the number of patent expiration of antidepressants hamper the market growth. On the contrary, increase in awareness regarding the disease state and rise in number of patients suffering from stress are expected to create lucrative opportunities for the market players in future.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2593
Obsessive-compulsive disorder segment to portray fastest demand through 2023
The obsessive-compulsive disorder segment is expected to register the fastest CAGR of 2.9% during the forecast period, owing to changing lifestyle and need for better quality of life. However, the major depressive disorder segment held the largest market share in 2017, contributing about 40% of the total revenue, as majority of the patients are diagnosed with this disorder due to high stress levels. The other segments analyzed in the report include generalized anxiety disorder, panic disorder, and others.
Selective serotonin reuptake inhibitors segment to lead the market by 2023
Selective serotonin reuptake inhibitors segment is projected to manifest the fastest CAGR of 2.7% during the forecast period, as these are highly effective in treat depression and anxiety due to their minimal side-effects. The other antidepressant products analyzed in the report are tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist and reuptake inhibitors, and others.
North America to retain the largest market share through 2023
North America accounted for the largest share in the market, contributing more than half of the total revenue, owing to increase in incidence of disorders such as stress, suicidal feelings, serious psychological disorders, and anxiety among the adult population in the region. However, Asia-Pacific region is expected to portray the fastest CAGR of 4.0% during the study period, owing to the increase in marketing approval for new medicines in the region and presence of large pool of geriatric population. The other regions analyzed in the report include Europe and Latin America, Middle East and Africa (LAMEA).
To know more about the report, visit the website at @ https://www.alliedmarketresearch.com/antidepressants-drugs-market
The Major Key Players Are:
• Alkermes Plc
• Allergan Plc
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• GlaxoSmithKline Plc
• H. Lundbeck
• Merck & Co., Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Co. Ltd.
The Other Prominent Players Are:
• Opko Health
• Intra-Cellular Therapies
• Janssen Pharmaceuticals
• Lupin
• Abbott Laboratories
• Novartis
• Forest Laboratories
• AstraZeneca
Similar Reports:
Narcolepsy Drugs Market : https://www.pharmiweb.com/press-release/2020-02-17/narcolepsy-drugs-market-size-is-predicted-to-touch-a-value-of-5-360-million-by-2026
Cholera Vaccine Market : https://www.pharmiweb.com/press-release/2020-02-17/cholera-vaccine-market-to-incur-steady-growth-207-million-by-2025-cagr-156
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidepressant Drugs Market Is Expected To Exhibit 2.1% CAGR By 2023 | Eli Lilly and Co., GlaxoSmithKline Plc here
News-ID: 2252667 • Views: …
More Releases from Allied Market Research
Low-Cost Airlines Market to Observe Highest Growth of USD 543.1 billion with Gro …
The global low cost airlines market was valued at $298.0 billion in 2023, and is projected to reach $543.1 billion by 2034, growing at a CAGR of 5.7% from 2024 to 2034
Request The Sample PDF of This Report: @ https://www.alliedmarketresearch.com/request-sample/4562
Low cost airlines, also known as budget or no-frills carriers, are airlines that offer low fares by minimizing traditional services and amenities. They typically use a single aircraft…
5G in Aviation Market Overview by Increasing Demands and Sales By 2021-2030
The global 5G in aviation market size was valued at $0.70 billion in 2020, and is projected to reach $4.68 billion by 2030, registering with a CAGR of 22.8% from 2021 to 2030.
The growth of the global 5G in aviation market is driven by growth in air passenger traffic across the globe, rise in inclination toward R&D activities for 5G network and related technology development, and changing aviation industry outlook.
Download…
Yerba Mate Market Current Trends, Future Prospects, and Competitive Landscape By …
The global yerba mate industry was generated $1.8 billion in 2022 and is anticipated to generate $2.9 billion by 2032, witnessing a CAGR of 5.2% from 2023 to 2032.
Yerba mate has strong cultural ties, especially in South America. As cultural diversity gains attention globally, there is an increasing interest in trying beverages with cultural significance. Yerba mate's unique cultural appeal contributes to its popularity among consumers seeking authentic and exotic…
Baby Care Products Market Trend to Eyewitness Huge Growth by 2031 | Baby Brezza, …
According to a new report published by Allied Market Research, titled, "Baby Care Products Market," The baby care products market size was valued at $38.0 billion in 2021, and is estimated to reach $58.8 billion by 2031, growing at a CAGR of 4.5% from 2022 to 2031.
➡️Download Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/17278
With the goal of promoting newborns' general health and wellbeing, the baby care products provide total skin…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
